These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34963110)

  • 1. Co-delivery of paclitaxel and doxorubicin using polypeptide-engineered nanogels for combination therapy of tumor.
    Yang J; Jin RM; Wang SY; Xie XT; Hu W; Tang HF; Liu B
    Nanotechnology; 2022 Jan; 33(15):. PubMed ID: 34963110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio.
    Baabur-Cohen H; Vossen LI; Krüger HR; Eldar-Boock A; Yeini E; Landa-Rouben N; Tiram G; Wedepohl S; Markovsky E; Leor J; Calderón M; Satchi-Fainaro R
    J Control Release; 2017 Jul; 257():118-131. PubMed ID: 27374630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An injectable hybrid hydrogel based on a genetically engineered polypeptide for second near-infrared fluorescence/photoacoustic imaging-monitored sustained chemo-photothermal therapy.
    Jin R; Yang X; Zhao D; Hou X; Li C; Song X; Chen W; Wang Q; Zhao Y; Liu B
    Nanoscale; 2019 Aug; 11(34):16080-16091. PubMed ID: 31432846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hollow gold nanoshells-incorporated injectable genetically engineered hydrogel for sustained chemo-photothermal therapy of tumor.
    Jin R; Yang J; Zhao D; Hou X; Li C; Chen W; Zhao Y; Yin Z; Liu B
    J Nanobiotechnology; 2019 Sep; 17(1):99. PubMed ID: 31530285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: preparation, in vitro and in vivo evaluation.
    Li Q; Lv S; Tang Z; Liu M; Zhang D; Yang Y; Chen X
    Int J Pharm; 2014 Aug; 471(1-2):412-20. PubMed ID: 24905776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor immunity triggered by photothermal therapy and photodynamic therapy of a 2D MoS
    Jin R; Yang J; Ding P; Li C; Zhang B; Chen W; Zhao YD; Cao Y; Liu B
    Nanotechnology; 2020 May; 31(20):205102. PubMed ID: 32018232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a biodegradable, versatile nanocarrier for optional combination cancer therapy.
    Wen J; Lv Y; Xu Y; Zhang P; Li H; Chen X; Li X; Zhang L; Liu F; Zeng W; Sun S
    Acta Biomater; 2019 Jan; 83():359-371. PubMed ID: 30414486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene/paclitaxel co-delivering nanocarriers prepared by framework-induced self-assembly for the inhibition of highly drug-resistant tumors.
    Wang C; Guan W; Peng J; Chen Y; Xu G; Dou H
    Acta Biomater; 2020 Feb; 103():247-258. PubMed ID: 31846802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a thermally responsive nanogel based on chitosan-poly(N-isopropylacrylamide-co-acrylamide) for paclitaxel delivery.
    Wang Y; Xu H; Wang J; Ge L; Zhu J
    J Pharm Sci; 2014 Jul; 103(7):2012-2021. PubMed ID: 24823900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer.
    Lv S; Tang Z; Li M; Lin J; Song W; Liu H; Huang Y; Zhang Y; Chen X
    Biomaterials; 2014 Jul; 35(23):6118-29. PubMed ID: 24794923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy.
    Li Y; Hou H; Zhang P; Zhang Z
    Drug Deliv; 2020 Dec; 27(1):1044-1053. PubMed ID: 32633576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung cancer combination therapy: co-delivery of paclitaxel and doxorubicin by nanostructured lipid carriers for synergistic effect.
    Wang Y; Zhang H; Hao J; Li B; Li M; Xiuwen W
    Drug Deliv; 2016 May; 23(4):1398-403. PubMed ID: 26079530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precise ratiometric loading of PTX and DOX based on redox-sensitive mixed micelles for cancer therapy.
    Zhao D; Wu J; Li C; Zhang H; Li Z; Luan Y
    Colloids Surf B Biointerfaces; 2017 Jul; 155():51-60. PubMed ID: 28407531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An improved method in fabrication of smart dual-responsive nanogels for controlled release of doxorubicin and curcumin in HT-29 colon cancer cells.
    Abedi F; Davaran S; Hekmati M; Akbarzadeh A; Baradaran B; Moghaddam SV
    J Nanobiotechnology; 2021 Jan; 19(1):18. PubMed ID: 33422062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(ethylene glycol)-co-methacrylamide-co-acrylic acid based nanogels for delivery of doxorubicin.
    Kumar P; Behl G; Sikka M; Chhikara A; Chopra M
    J Biomater Sci Polym Ed; 2016 Oct; 27(14):1413-33. PubMed ID: 27383582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellularly Swollen Polypeptide Nanogel Assists Hepatoma Chemotherapy.
    Shi B; Huang K; Ding J; Xu W; Yang Y; Liu H; Yan L; Chen X
    Theranostics; 2017; 7(3):703-716. PubMed ID: 28255361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-Based Hydrogels and Nanogels for Delivery of Doxorubicin.
    Gallo E; Diaferia C; Rosa E; Smaldone G; Morelli G; Accardo A
    Int J Nanomedicine; 2021; 16():1617-1630. PubMed ID: 33688182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.
    Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O
    Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin-loaded environmentally friendly carbon dots as a novel drug delivery system for nucleus targeted cancer therapy.
    Yuan Y; Guo B; Hao L; Liu N; Lin Y; Guo W; Li X; Gu B
    Colloids Surf B Biointerfaces; 2017 Nov; 159():349-359. PubMed ID: 28806666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.